Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myopathies, Structural, Congenital | 42 | 2023 | 102 | 10.320 |
Why?
|
Myopathies, Nemaline | 36 | 2021 | 72 | 5.650 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 22 | 2022 | 66 | 4.070 |
Why?
|
Muscle Proteins | 39 | 2024 | 1158 | 3.000 |
Why?
|
Muscle, Skeletal | 88 | 2024 | 4925 | 2.980 |
Why?
|
Actinin | 23 | 2021 | 160 | 2.440 |
Why?
|
Muscular Diseases | 23 | 2024 | 555 | 2.340 |
Why?
|
Muscular Dystrophies | 32 | 2019 | 393 | 2.220 |
Why?
|
Sarcomeres | 13 | 2021 | 374 | 1.990 |
Why?
|
Anemia, Diamond-Blackfan | 12 | 2018 | 137 | 1.850 |
Why?
|
Zebrafish | 22 | 2024 | 2996 | 1.770 |
Why?
|
Mutation | 78 | 2024 | 29786 | 1.330 |
Why?
|
Tropomyosin | 6 | 2015 | 102 | 1.250 |
Why?
|
Neonatal Screening | 10 | 2023 | 591 | 1.230 |
Why?
|
Ribosomal Proteins | 10 | 2018 | 360 | 1.220 |
Why?
|
Myofibrils | 7 | 2016 | 146 | 1.170 |
Why?
|
Cofilin 2 | 5 | 2020 | 12 | 1.150 |
Why?
|
Swimming | 3 | 2023 | 205 | 1.090 |
Why?
|
Muscle Fibers, Skeletal | 16 | 2021 | 555 | 1.060 |
Why?
|
Genetic Testing | 19 | 2023 | 3444 | 1.060 |
Why?
|
Mutation, Missense | 16 | 2017 | 2566 | 1.020 |
Why?
|
Zebrafish Proteins | 6 | 2020 | 1005 | 1.020 |
Why?
|
Genetic Diseases, X-Linked | 5 | 2023 | 372 | 1.010 |
Why?
|
Actins | 25 | 2024 | 2121 | 0.980 |
Why?
|
Selenoproteins | 5 | 2020 | 216 | 0.970 |
Why?
|
Activin Receptors, Type II | 3 | 2016 | 127 | 0.950 |
Why?
|
Dystrophin | 25 | 2005 | 285 | 0.940 |
Why?
|
Microfilament Proteins | 13 | 2024 | 1152 | 0.850 |
Why?
|
Cardiac Myosins | 2 | 2019 | 117 | 0.790 |
Why?
|
Neuromuscular Diseases | 6 | 2019 | 247 | 0.760 |
Why?
|
Phenotype | 51 | 2024 | 16367 | 0.730 |
Why?
|
Muscle Weakness | 8 | 2023 | 413 | 0.710 |
Why?
|
Muscles | 17 | 2024 | 1614 | 0.690 |
Why?
|
Myosin Light Chains | 1 | 2019 | 121 | 0.690 |
Why?
|
Point Mutation | 8 | 2018 | 1624 | 0.670 |
Why?
|
Laminin | 3 | 2012 | 419 | 0.630 |
Why?
|
Respiration, Artificial | 3 | 2020 | 2569 | 0.620 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2018 | 851 | 0.620 |
Why?
|
Exons | 14 | 2023 | 2439 | 0.590 |
Why?
|
Genetic Association Studies | 12 | 2019 | 2703 | 0.580 |
Why?
|
RNA, Ribosomal | 4 | 2018 | 246 | 0.580 |
Why?
|
Disease Models, Animal | 23 | 2022 | 18034 | 0.580 |
Why?
|
Genetic Predisposition to Disease | 18 | 2023 | 17445 | 0.580 |
Why?
|
Satellite Cells, Skeletal Muscle | 3 | 2014 | 124 | 0.560 |
Why?
|
Muscular Dystrophy, Duchenne | 7 | 2021 | 256 | 0.540 |
Why?
|
Pedigree | 29 | 2019 | 4642 | 0.530 |
Why?
|
Long QT Syndrome | 6 | 2002 | 453 | 0.520 |
Why?
|
X Chromosome | 9 | 2012 | 814 | 0.500 |
Why?
|
Dog Diseases | 2 | 2015 | 138 | 0.470 |
Why?
|
Hypertrichosis | 1 | 2013 | 25 | 0.470 |
Why?
|
KATP Channels | 1 | 2013 | 45 | 0.460 |
Why?
|
Infant | 48 | 2023 | 35134 | 0.460 |
Why?
|
Muscle Fibers, Slow-Twitch | 5 | 2016 | 49 | 0.450 |
Why?
|
Infant, Newborn | 31 | 2023 | 25628 | 0.450 |
Why?
|
Child, Preschool | 52 | 2023 | 41005 | 0.440 |
Why?
|
Muscle Strength | 4 | 2023 | 592 | 0.440 |
Why?
|
Neurofilament Proteins | 1 | 2014 | 318 | 0.430 |
Why?
|
Child | 70 | 2023 | 77708 | 0.430 |
Why?
|
Enzyme Replacement Therapy | 1 | 2013 | 78 | 0.430 |
Why?
|
Frameshift Mutation | 4 | 2013 | 399 | 0.430 |
Why?
|
Humans | 236 | 2024 | 744376 | 0.420 |
Why?
|
Osteochondrodysplasias | 1 | 2013 | 183 | 0.420 |
Why?
|
Muscle Contraction | 10 | 2018 | 1235 | 0.420 |
Why?
|
Parents | 9 | 2022 | 3405 | 0.410 |
Why?
|
Animals | 81 | 2024 | 168770 | 0.410 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2013 | 475 | 0.410 |
Why?
|
Myoblasts | 4 | 2018 | 238 | 0.410 |
Why?
|
Protein Isoforms | 11 | 2018 | 1730 | 0.410 |
Why?
|
Base Sequence | 26 | 2017 | 12797 | 0.400 |
Why?
|
Dystroglycans | 2 | 2011 | 60 | 0.400 |
Why?
|
Genomics | 12 | 2023 | 5717 | 0.400 |
Why?
|
RNA Splice Sites | 1 | 2012 | 209 | 0.390 |
Why?
|
Genes, Dominant | 7 | 2012 | 880 | 0.380 |
Why?
|
Abnormalities, Multiple | 4 | 2012 | 1416 | 0.380 |
Why?
|
Cardiomegaly | 1 | 2013 | 620 | 0.370 |
Why?
|
Ophthalmoplegia | 4 | 1998 | 166 | 0.370 |
Why?
|
Male | 128 | 2024 | 350118 | 0.370 |
Why?
|
Protein Biosynthesis | 4 | 2018 | 2126 | 0.370 |
Why?
|
Distal Myopathies | 2 | 2024 | 16 | 0.370 |
Why?
|
Rare Diseases | 3 | 2021 | 553 | 0.360 |
Why?
|
Health | 2 | 2019 | 394 | 0.360 |
Why?
|
Gene Deletion | 7 | 2018 | 2751 | 0.350 |
Why?
|
DNA Copy Number Variations | 8 | 2024 | 1941 | 0.350 |
Why?
|
Sudden Infant Death | 2 | 2009 | 291 | 0.350 |
Why?
|
Chromosomes, Human, Pair 1 | 6 | 2002 | 658 | 0.340 |
Why?
|
Carrier Proteins | 5 | 2018 | 5023 | 0.340 |
Why?
|
Premature Birth | 2 | 2019 | 1721 | 0.340 |
Why?
|
Ubiquitination | 1 | 2013 | 1012 | 0.330 |
Why?
|
Drug Discovery | 4 | 2023 | 1058 | 0.330 |
Why?
|
Mice | 40 | 2022 | 81202 | 0.320 |
Why?
|
INDEL Mutation | 1 | 2009 | 279 | 0.320 |
Why?
|
Genes | 5 | 2003 | 1893 | 0.320 |
Why?
|
Dynamin II | 4 | 2013 | 35 | 0.320 |
Why?
|
Proteins | 2 | 2013 | 6100 | 0.320 |
Why?
|
Genetic Linkage | 12 | 2015 | 2421 | 0.310 |
Why?
|
Sequence Analysis, DNA | 10 | 2019 | 4805 | 0.310 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2007 | 473 | 0.310 |
Why?
|
Polymerase Chain Reaction | 16 | 2011 | 6171 | 0.300 |
Why?
|
Dependovirus | 5 | 2021 | 706 | 0.300 |
Why?
|
Gene Expression Profiling | 14 | 2019 | 9445 | 0.300 |
Why?
|
Mice, Knockout | 15 | 2020 | 14561 | 0.290 |
Why?
|
Nuclear Proteins | 5 | 2018 | 5857 | 0.290 |
Why?
|
Cell Cycle | 5 | 2019 | 2968 | 0.290 |
Why?
|
Thumb | 1 | 2008 | 227 | 0.290 |
Why?
|
Developmental Disabilities | 4 | 2020 | 1456 | 0.280 |
Why?
|
Blotting, Western | 11 | 2016 | 5181 | 0.280 |
Why?
|
Sodium Channels | 3 | 2010 | 349 | 0.280 |
Why?
|
Genotype | 18 | 2023 | 12952 | 0.270 |
Why?
|
DNA Mutational Analysis | 18 | 2017 | 4185 | 0.270 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1876 | 0.270 |
Why?
|
Molecular Sequence Data | 30 | 2014 | 18111 | 0.270 |
Why?
|
Heterozygote | 9 | 2023 | 2804 | 0.270 |
Why?
|
Databases, Genetic | 9 | 2021 | 1783 | 0.270 |
Why?
|
Potassium Channels | 3 | 1998 | 563 | 0.270 |
Why?
|
Psychotic Disorders | 4 | 2023 | 3046 | 0.260 |
Why?
|
Chromosomes, Human, Pair 12 | 3 | 1997 | 462 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2504 | 0.260 |
Why?
|
Female | 101 | 2021 | 380200 | 0.260 |
Why?
|
Computational Biology | 5 | 2023 | 3519 | 0.260 |
Why?
|
Blepharoptosis | 3 | 1998 | 143 | 0.250 |
Why?
|
Genetic Variation | 12 | 2019 | 6542 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 12 | 2010 | 3921 | 0.250 |
Why?
|
Truth Disclosure | 2 | 2019 | 436 | 0.250 |
Why?
|
Drosophila Proteins | 1 | 2014 | 1703 | 0.250 |
Why?
|
Chromosome Mapping | 21 | 2021 | 4740 | 0.240 |
Why?
|
Transcription Factors | 6 | 2021 | 12209 | 0.240 |
Why?
|
Amino Acid Sequence | 19 | 2021 | 13814 | 0.240 |
Why?
|
Cytoskeletal Proteins | 5 | 2018 | 1364 | 0.240 |
Why?
|
Transcription, Genetic | 7 | 2006 | 7722 | 0.240 |
Why?
|
Genes, Recessive | 8 | 2013 | 641 | 0.230 |
Why?
|
Signal Transduction | 9 | 2021 | 23406 | 0.230 |
Why?
|
Fluorescent Antibody Technique, Indirect | 4 | 2012 | 429 | 0.230 |
Why?
|
Contractile Proteins | 2 | 2003 | 246 | 0.230 |
Why?
|
Chromosome Deletion | 10 | 2016 | 1401 | 0.230 |
Why?
|
Genetic Counseling | 2 | 2018 | 600 | 0.230 |
Why?
|
Genome, Human | 6 | 2023 | 4420 | 0.230 |
Why?
|
Larva | 2 | 2023 | 519 | 0.220 |
Why?
|
Cleft Palate | 1 | 2008 | 560 | 0.220 |
Why?
|
Dogs | 8 | 2017 | 3912 | 0.220 |
Why?
|
Longevity | 1 | 2011 | 1071 | 0.220 |
Why?
|
Genetic Diseases, Inborn | 2 | 2018 | 587 | 0.220 |
Why?
|
Genetic Heterogeneity | 3 | 2015 | 733 | 0.220 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2016 | 354 | 0.220 |
Why?
|
Hypophosphatemia | 1 | 2023 | 85 | 0.210 |
Why?
|
Phosphatidylinositol Phosphates | 2 | 2014 | 209 | 0.210 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2019 | 3596 | 0.210 |
Why?
|
DNA Primers | 7 | 2012 | 2891 | 0.210 |
Why?
|
Actomyosin | 1 | 2023 | 111 | 0.210 |
Why?
|
Gene Expression Regulation | 13 | 2021 | 12073 | 0.210 |
Why?
|
GATA1 Transcription Factor | 2 | 2014 | 293 | 0.210 |
Why?
|
DEAD-box RNA Helicases | 2 | 2018 | 375 | 0.210 |
Why?
|
RNA, Messenger | 14 | 2020 | 13035 | 0.210 |
Why?
|
Sarcoplasmic Reticulum | 2 | 2014 | 158 | 0.210 |
Why?
|
Biopsy | 17 | 2019 | 6755 | 0.200 |
Why?
|
Sequence Deletion | 4 | 2012 | 1526 | 0.200 |
Why?
|
Muscle Fibers, Fast-Twitch | 5 | 2016 | 69 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2012 | 2949 | 0.200 |
Why?
|
JC Virus | 3 | 1994 | 85 | 0.200 |
Why?
|
Adolescent | 37 | 2023 | 85784 | 0.200 |
Why?
|
Adult | 58 | 2023 | 214056 | 0.190 |
Why?
|
Directed Molecular Evolution | 1 | 2021 | 160 | 0.190 |
Why?
|
Potassium Channels, Voltage-Gated | 2 | 1998 | 142 | 0.180 |
Why?
|
Antigens, Viral, Tumor | 3 | 1990 | 156 | 0.180 |
Why?
|
Glycolysis | 2 | 2009 | 829 | 0.180 |
Why?
|
Calcium | 7 | 2018 | 5755 | 0.180 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 4 | 2019 | 175 | 0.180 |
Why?
|
Amino Acid Transport System y+ | 1 | 2019 | 35 | 0.180 |
Why?
|
Models, Molecular | 8 | 2018 | 5451 | 0.180 |
Why?
|
Muscle Relaxation | 1 | 2020 | 142 | 0.180 |
Why?
|
Gene Expression | 8 | 2018 | 7798 | 0.170 |
Why?
|
Muscle Development | 3 | 2018 | 271 | 0.170 |
Why?
|
Myosin Heavy Chains | 3 | 2023 | 414 | 0.170 |
Why?
|
Age of Onset | 4 | 2019 | 3270 | 0.170 |
Why?
|
Microscopy, Electron | 4 | 2017 | 2646 | 0.170 |
Why?
|
Muscle Hypotonia | 1 | 2020 | 165 | 0.170 |
Why?
|
Autistic Disorder | 2 | 2021 | 1185 | 0.170 |
Why?
|
Troponin T | 2 | 2020 | 754 | 0.170 |
Why?
|
Capsid | 1 | 2021 | 437 | 0.170 |
Why?
|
Fatal Outcome | 5 | 2019 | 1851 | 0.170 |
Why?
|
Biotinidase | 1 | 2018 | 19 | 0.170 |
Why?
|
Histone Deacetylases | 2 | 2020 | 728 | 0.160 |
Why?
|
Family | 2 | 2021 | 3147 | 0.160 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2019 | 90 | 0.160 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.160 |
Why?
|
Polyomavirus | 2 | 1990 | 249 | 0.160 |
Why?
|
Eczema | 1 | 2020 | 231 | 0.160 |
Why?
|
Blotting, Northern | 6 | 2012 | 1581 | 0.160 |
Why?
|
Sequence Alignment | 5 | 2014 | 2256 | 0.160 |
Why?
|
Patient Acceptance of Health Care | 2 | 2023 | 3020 | 0.150 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2017 | 40 | 0.150 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2018 | 100 | 0.150 |
Why?
|
DNA-Binding Proteins | 2 | 2009 | 9647 | 0.150 |
Why?
|
Haplotypes | 6 | 2010 | 2779 | 0.150 |
Why?
|
Myosins | 4 | 2015 | 409 | 0.150 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.150 |
Why?
|
Myasthenic Syndromes, Congenital | 1 | 2017 | 18 | 0.150 |
Why?
|
Apoptosis Inducing Factor | 1 | 2017 | 55 | 0.150 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2017 | 37 | 0.150 |
Why?
|
Agrin | 1 | 2017 | 68 | 0.150 |
Why?
|
Disease Progression | 8 | 2021 | 13285 | 0.150 |
Why?
|
Hybrid Cells | 4 | 1995 | 441 | 0.150 |
Why?
|
Oculomotor Nerve | 1 | 1997 | 74 | 0.140 |
Why?
|
Medulla Oblongata | 2 | 2009 | 243 | 0.140 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2918 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 655 | 0.140 |
Why?
|
Oculomotor Muscles | 2 | 1998 | 371 | 0.140 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2016 | 30 | 0.140 |
Why?
|
Depression, Postpartum | 1 | 2021 | 340 | 0.140 |
Why?
|
Lod Score | 8 | 2001 | 614 | 0.140 |
Why?
|
Apoptosis | 4 | 2015 | 9726 | 0.140 |
Why?
|
Cell Line | 13 | 2018 | 16000 | 0.140 |
Why?
|
Microcephaly | 1 | 2020 | 432 | 0.140 |
Why?
|
Health Care Costs | 2 | 2021 | 3209 | 0.140 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2017 | 94 | 0.140 |
Why?
|
Ribosomes | 4 | 2018 | 500 | 0.140 |
Why?
|
Gene Transfer Techniques | 1 | 2021 | 1225 | 0.140 |
Why?
|
Cytoskeleton | 3 | 2021 | 1185 | 0.140 |
Why?
|
Myokymia | 1 | 2015 | 11 | 0.140 |
Why?
|
Diaphragm | 2 | 2014 | 349 | 0.130 |
Why?
|
Kv1.1 Potassium Channel | 1 | 2015 | 29 | 0.130 |
Why?
|
Epilepsies, Myoclonic | 1 | 2016 | 80 | 0.130 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2015 | 22 | 0.130 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 1998 | 417 | 0.130 |
Why?
|
Craniofacial Abnormalities | 1 | 2018 | 315 | 0.130 |
Why?
|
Two-Hybrid System Techniques | 2 | 2014 | 464 | 0.130 |
Why?
|
Growth Disorders | 1 | 2020 | 645 | 0.130 |
Why?
|
Polymorphism, Single-Stranded Conformational | 5 | 2004 | 335 | 0.130 |
Why?
|
Obesity Hypoventilation Syndrome | 1 | 2015 | 17 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 4751 | 0.130 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 618 | 0.130 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2017 | 266 | 0.130 |
Why?
|
Cation Transport Proteins | 1 | 1998 | 327 | 0.130 |
Why?
|
Polymorphism, Genetic | 8 | 2012 | 4328 | 0.130 |
Why?
|
Cataplexy | 1 | 2015 | 60 | 0.130 |
Why?
|
Dosage Compensation, Genetic | 3 | 1995 | 211 | 0.130 |
Why?
|
GTPase-Activating Proteins | 1 | 2018 | 498 | 0.130 |
Why?
|
Chromosomes, Human, Pair 2 | 5 | 2014 | 326 | 0.130 |
Why?
|
Age Factors | 5 | 2019 | 18373 | 0.120 |
Why?
|
Mice, Inbred C57BL | 8 | 2021 | 21833 | 0.120 |
Why?
|
Health Resources | 1 | 2021 | 911 | 0.120 |
Why?
|
Microscopy, Electron, Transmission | 4 | 2012 | 712 | 0.120 |
Why?
|
Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2014 | 13 | 0.120 |
Why?
|
Mice, Mutant Strains | 2 | 2016 | 1865 | 0.120 |
Why?
|
Hepatomegaly | 1 | 2014 | 85 | 0.120 |
Why?
|
Lung | 1 | 2013 | 9857 | 0.120 |
Why?
|
Myotonia Congenita | 1 | 2013 | 16 | 0.120 |
Why?
|
Embryonic Development | 1 | 2019 | 711 | 0.120 |
Why?
|
Escape Reaction | 1 | 2013 | 54 | 0.120 |
Why?
|
Turkey | 1 | 2014 | 237 | 0.120 |
Why?
|
Hypothalamic Diseases | 1 | 2015 | 135 | 0.120 |
Why?
|
Genetics, Population | 1 | 1999 | 934 | 0.120 |
Why?
|
Trans-Activators | 3 | 2021 | 2926 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1031 | 0.120 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 824 | 0.120 |
Why?
|
Codon, Terminator | 4 | 2002 | 127 | 0.120 |
Why?
|
Gene Order | 1 | 2013 | 176 | 0.110 |
Why?
|
Ataxia | 1 | 2015 | 304 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1375 | 0.110 |
Why?
|
Tissue Fixation | 1 | 2014 | 241 | 0.110 |
Why?
|
Disease | 1 | 2019 | 680 | 0.110 |
Why?
|
Medical Records | 1 | 2018 | 1413 | 0.110 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1992 | 769 | 0.110 |
Why?
|
Expressed Sequence Tags | 2 | 2003 | 255 | 0.110 |
Why?
|
Young Adult | 14 | 2021 | 56434 | 0.110 |
Why?
|
Walker-Warburg Syndrome | 1 | 2012 | 14 | 0.110 |
Why?
|
Myostatin | 2 | 2011 | 124 | 0.110 |
Why?
|
Genetic Vectors | 4 | 2017 | 3424 | 0.110 |
Why?
|
Phosphatidylinositols | 1 | 2014 | 291 | 0.110 |
Why?
|
Kinetics | 3 | 2024 | 6476 | 0.110 |
Why?
|
Calmodulin | 2 | 2008 | 209 | 0.110 |
Why?
|
Attitude to Health | 2 | 2019 | 2052 | 0.110 |
Why?
|
Gait | 2 | 2017 | 793 | 0.110 |
Why?
|
Immunohistochemistry | 13 | 2018 | 11366 | 0.110 |
Why?
|
Cell Membrane | 4 | 2012 | 3749 | 0.110 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 257 | 0.110 |
Why?
|
Pyrazines | 2 | 2021 | 1230 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2015 | 347 | 0.100 |
Why?
|
Nervous System Diseases | 1 | 2023 | 1622 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1629 | 0.100 |
Why?
|
Imidazoles | 2 | 2021 | 1206 | 0.100 |
Why?
|
Glycosyltransferases | 1 | 2012 | 113 | 0.100 |
Why?
|
Selenocysteine | 1 | 2013 | 124 | 0.100 |
Why?
|
Gene Expression Regulation, Viral | 2 | 1994 | 442 | 0.100 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 2 | 1988 | 68 | 0.100 |
Why?
|
Protein Conformation | 4 | 2018 | 4010 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 3390 | 0.100 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1992 | 798 | 0.100 |
Why?
|
Catalysis | 1 | 2013 | 762 | 0.100 |
Why?
|
Gene Duplication | 1 | 2012 | 329 | 0.100 |
Why?
|
Protein Stability | 1 | 2013 | 556 | 0.100 |
Why?
|
Regeneration | 3 | 2018 | 1485 | 0.100 |
Why?
|
Amino Acid Substitution | 4 | 2013 | 1793 | 0.100 |
Why?
|
Gravitation | 1 | 2011 | 82 | 0.100 |
Why?
|
Schizophrenia | 2 | 2023 | 6882 | 0.100 |
Why?
|
Gene Frequency | 4 | 2009 | 3587 | 0.100 |
Why?
|
Peer Review, Research | 1 | 2014 | 329 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2010 | 2839 | 0.100 |
Why?
|
Forelimb | 1 | 2011 | 122 | 0.100 |
Why?
|
Desmin | 1 | 2010 | 130 | 0.090 |
Why?
|
In Situ Hybridization | 2 | 2012 | 1950 | 0.090 |
Why?
|
Cells, Cultured | 12 | 2021 | 19233 | 0.090 |
Why?
|
Homozygote | 4 | 2017 | 1787 | 0.090 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 293 | 0.090 |
Why?
|
Motion | 1 | 2014 | 798 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 3 | 2018 | 496 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1708 | 0.090 |
Why?
|
Quality of Life | 2 | 2022 | 12803 | 0.090 |
Why?
|
Multigene Family | 4 | 2002 | 1102 | 0.090 |
Why?
|
Neuromuscular Junction | 1 | 2012 | 397 | 0.090 |
Why?
|
COS Cells | 2 | 2010 | 1161 | 0.090 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2010 | 61 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2013 | 1591 | 0.090 |
Why?
|
Cell Fusion | 2 | 2006 | 297 | 0.090 |
Why?
|
Tissue Distribution | 5 | 2019 | 2327 | 0.090 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2018 | 1444 | 0.090 |
Why?
|
Sepsis | 1 | 2023 | 2593 | 0.090 |
Why?
|
Cell Differentiation | 4 | 2017 | 11486 | 0.090 |
Why?
|
Ribosome Subunits, Large | 1 | 2008 | 5 | 0.090 |
Why?
|
Ribosome Subunits, Small | 1 | 2008 | 5 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 3024 | 0.090 |
Why?
|
Dinucleoside Phosphates | 1 | 1989 | 74 | 0.090 |
Why?
|
Facies | 2 | 2020 | 197 | 0.080 |
Why?
|
Cohort Studies | 9 | 2022 | 40558 | 0.080 |
Why?
|
HeLa Cells | 2 | 2013 | 3130 | 0.080 |
Why?
|
Troponin | 1 | 2013 | 524 | 0.080 |
Why?
|
Cell Transformation, Viral | 2 | 1990 | 567 | 0.080 |
Why?
|
Mitochondria, Muscle | 2 | 2010 | 171 | 0.080 |
Why?
|
Cloning, Molecular | 8 | 2001 | 4320 | 0.080 |
Why?
|
Alleles | 7 | 2023 | 6933 | 0.080 |
Why?
|
Recombination, Genetic | 3 | 2021 | 1586 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2183 | 0.080 |
Why?
|
Physical Fitness | 2 | 2003 | 732 | 0.080 |
Why?
|
Founder Effect | 1 | 2009 | 189 | 0.080 |
Why?
|
Genes, Viral | 2 | 1986 | 718 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2213 | 0.080 |
Why?
|
DNA | 13 | 2008 | 7294 | 0.080 |
Why?
|
Longitudinal Studies | 6 | 2022 | 13988 | 0.080 |
Why?
|
Blotting, Southern | 6 | 1993 | 803 | 0.080 |
Why?
|
RNA, Small Interfering | 3 | 2013 | 3505 | 0.080 |
Why?
|
Myocardium | 3 | 2014 | 4772 | 0.080 |
Why?
|
Hand Strength | 1 | 2011 | 448 | 0.080 |
Why?
|
Fatty Liver | 1 | 2014 | 727 | 0.080 |
Why?
|
Genetic Markers | 8 | 2004 | 2634 | 0.080 |
Why?
|
Serotonin | 2 | 2009 | 1017 | 0.080 |
Why?
|
DNA, Complementary | 5 | 2004 | 2050 | 0.080 |
Why?
|
Enzymes | 1 | 2009 | 266 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 4 | 2004 | 2505 | 0.080 |
Why?
|
Myositis, Inclusion Body | 1 | 2009 | 147 | 0.080 |
Why?
|
Polymyositis | 1 | 2007 | 75 | 0.080 |
Why?
|
Models, Biological | 3 | 2018 | 9584 | 0.070 |
Why?
|
DNA Methylation | 2 | 2019 | 4287 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2019 | 1912 | 0.070 |
Why?
|
Cell Count | 3 | 2012 | 1856 | 0.070 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1656 | 0.070 |
Why?
|
Middle Aged | 27 | 2021 | 213388 | 0.070 |
Why?
|
Introns | 1 | 2009 | 992 | 0.070 |
Why?
|
Cell Separation | 3 | 2011 | 1751 | 0.070 |
Why?
|
Defective Viruses | 1 | 1986 | 112 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2670 | 0.070 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2006 | 62 | 0.070 |
Why?
|
Pediatrics | 2 | 2019 | 3475 | 0.070 |
Why?
|
Personal Autonomy | 2 | 2019 | 298 | 0.070 |
Why?
|
Fibroblasts | 5 | 2019 | 4162 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3773 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2864 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2006 | 78 | 0.070 |
Why?
|
Calcium Signaling | 2 | 2018 | 721 | 0.070 |
Why?
|
Simian virus 40 | 1 | 1986 | 297 | 0.070 |
Why?
|
Case-Control Studies | 7 | 2016 | 21747 | 0.070 |
Why?
|
Epilepsy | 2 | 2018 | 3310 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2850 | 0.070 |
Why?
|
Fibrosis | 4 | 1998 | 2029 | 0.070 |
Why?
|
Receptors, Serotonin | 1 | 2006 | 201 | 0.070 |
Why?
|
Transgenes | 2 | 2021 | 1009 | 0.070 |
Why?
|
Interferon-beta | 1 | 2007 | 324 | 0.070 |
Why?
|
MicroRNAs | 2 | 2015 | 3751 | 0.070 |
Why?
|
Genetic Research | 2 | 2017 | 174 | 0.070 |
Why?
|
Erythroid Precursor Cells | 1 | 2006 | 218 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3658 | 0.070 |
Why?
|
Fatigue | 1 | 2013 | 1531 | 0.070 |
Why?
|
Telephone | 2 | 2020 | 617 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2021 | 77459 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 3 | 2005 | 2269 | 0.060 |
Why?
|
Hematopoiesis | 2 | 2012 | 2073 | 0.060 |
Why?
|
Dermatomyositis | 1 | 2007 | 224 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1205 | 0.060 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2008 | 689 | 0.060 |
Why?
|
Down-Regulation | 4 | 2009 | 3001 | 0.060 |
Why?
|
Membrane Proteins | 5 | 2012 | 7882 | 0.060 |
Why?
|
Syndrome | 4 | 2018 | 3252 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3842 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2088 | 0.060 |
Why?
|
Respiratory Function Tests | 2 | 2021 | 1617 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1741 | 0.060 |
Why?
|
Immunoblotting | 6 | 2010 | 1683 | 0.060 |
Why?
|
Species Specificity | 2 | 2021 | 2478 | 0.060 |
Why?
|
Phylogeny | 1 | 2012 | 2804 | 0.060 |
Why?
|
Binding Sites | 6 | 2010 | 6111 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1213 | 0.060 |
Why?
|
Motor Activity | 2 | 2012 | 2715 | 0.060 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 175 | 0.060 |
Why?
|
Software | 1 | 2018 | 4442 | 0.060 |
Why?
|
Postmortem Changes | 1 | 2004 | 124 | 0.060 |
Why?
|
Survival Analysis | 3 | 2017 | 10252 | 0.060 |
Why?
|
PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2023 | 17 | 0.060 |
Why?
|
Culture Media | 1 | 1986 | 909 | 0.060 |
Why?
|
Selenium | 1 | 2006 | 405 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2602 | 0.060 |
Why?
|
Calcium Channels, L-Type | 1 | 2005 | 240 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4644 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2007 | 2715 | 0.060 |
Why?
|
Growth Substances | 1 | 1986 | 784 | 0.060 |
Why?
|
Interferon-alpha | 1 | 2007 | 895 | 0.060 |
Why?
|
Protein Multimerization | 2 | 2021 | 971 | 0.060 |
Why?
|
Paraproteinemias | 1 | 2006 | 246 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2006 | 767 | 0.060 |
Why?
|
Bone Marrow Cells | 3 | 2006 | 2513 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2021 | 2969 | 0.050 |
Why?
|
Risk Assessment | 3 | 2019 | 23336 | 0.050 |
Why?
|
Behavior, Animal | 1 | 2011 | 1881 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15535 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2018 | 12961 | 0.050 |
Why?
|
Glycogen | 1 | 2003 | 259 | 0.050 |
Why?
|
Mice, Transgenic | 4 | 2013 | 9735 | 0.050 |
Why?
|
France | 1 | 2023 | 517 | 0.050 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2001 | 367 | 0.050 |
Why?
|
Australia | 2 | 2003 | 1167 | 0.050 |
Why?
|
Syncope | 3 | 2002 | 429 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 1998 | 896 | 0.050 |
Why?
|
Binding, Competitive | 2 | 2001 | 1157 | 0.050 |
Why?
|
RNA | 4 | 2005 | 2749 | 0.050 |
Why?
|
Appendicitis | 1 | 2008 | 645 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3084 | 0.050 |
Why?
|
Fetus | 3 | 2006 | 1880 | 0.050 |
Why?
|
United States | 4 | 2023 | 69869 | 0.050 |
Why?
|
Embryo, Nonmammalian | 2 | 2018 | 895 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2001 | 460 | 0.050 |
Why?
|
Germany | 1 | 2023 | 862 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7281 | 0.050 |
Why?
|
Sialorrhea | 1 | 2021 | 25 | 0.050 |
Why?
|
Eye Diseases, Hereditary | 1 | 2002 | 117 | 0.050 |
Why?
|
Probability | 3 | 2020 | 2506 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2023 | 513 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2009 | 1889 | 0.050 |
Why?
|
Respiratory Insufficiency | 2 | 2017 | 1199 | 0.050 |
Why?
|
RNA Splicing | 2 | 2018 | 908 | 0.050 |
Why?
|
Serum Response Factor | 1 | 2021 | 81 | 0.050 |
Why?
|
Wheelchairs | 1 | 2021 | 77 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2007 | 2373 | 0.050 |
Why?
|
Adenosine Triphosphatases | 2 | 2017 | 839 | 0.050 |
Why?
|
Hemangioma | 1 | 2005 | 738 | 0.050 |
Why?
|
Phosphorylation | 2 | 2014 | 8437 | 0.050 |
Why?
|
Intermediate Filament Proteins | 1 | 2001 | 269 | 0.050 |
Why?
|
Protein Binding | 3 | 2024 | 9384 | 0.040 |
Why?
|
Oligonucleotide Probes | 2 | 1990 | 427 | 0.040 |
Why?
|
Antigens, CD34 | 2 | 2017 | 659 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2001 | 373 | 0.040 |
Why?
|
Body Weight | 1 | 2011 | 4671 | 0.040 |
Why?
|
Eye Abnormalities | 1 | 2002 | 246 | 0.040 |
Why?
|
Oncogenes | 1 | 1986 | 1265 | 0.040 |
Why?
|
Cell Division | 2 | 2003 | 4569 | 0.040 |
Why?
|
Myositis | 1 | 2002 | 251 | 0.040 |
Why?
|
Intubation, Gastrointestinal | 1 | 2020 | 153 | 0.040 |
Why?
|
Valproic Acid | 1 | 2022 | 445 | 0.040 |
Why?
|
Models, Animal | 2 | 2017 | 2173 | 0.040 |
Why?
|
North America | 1 | 2003 | 1249 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 915 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 418 | 0.040 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1999 | 170 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4208 | 0.040 |
Why?
|
DNA, Satellite | 2 | 1996 | 69 | 0.040 |
Why?
|
Rhabdomyolysis | 1 | 2020 | 150 | 0.040 |
Why?
|
Aging | 3 | 2005 | 8663 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2001 | 319 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1999 | 287 | 0.040 |
Why?
|
Siblings | 2 | 2019 | 854 | 0.040 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 1998 | 70 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 163 | 0.040 |
Why?
|
PAX2 Transcription Factor | 1 | 2018 | 80 | 0.040 |
Why?
|
Gastrostomy | 1 | 2020 | 310 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 194 | 0.040 |
Why?
|
Exotropia | 1 | 1998 | 55 | 0.040 |
Why?
|
Muscular Atrophy, Spinal | 2 | 2002 | 259 | 0.040 |
Why?
|
Vital Capacity | 1 | 2020 | 925 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2008 | 3486 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 1999 | 281 | 0.040 |
Why?
|
Transfection | 5 | 2010 | 5895 | 0.040 |
Why?
|
Harm Reduction | 1 | 2019 | 129 | 0.040 |
Why?
|
Leg | 1 | 2003 | 1116 | 0.040 |
Why?
|
Collagen Type VI | 1 | 2017 | 26 | 0.040 |
Why?
|
Cell Nucleolus | 1 | 2018 | 166 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3647 | 0.040 |
Why?
|
Allyl Compounds | 1 | 2017 | 23 | 0.040 |
Why?
|
Strabismus | 2 | 2002 | 287 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 214 | 0.040 |
Why?
|
Chromatin | 1 | 1989 | 2934 | 0.040 |
Why?
|
Creatine Kinase | 2 | 1996 | 694 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1998 | 322 | 0.040 |
Why?
|
Tetany | 1 | 2016 | 12 | 0.040 |
Why?
|
Neoplasms | 1 | 2006 | 21693 | 0.040 |
Why?
|
Tracheostomy | 1 | 2021 | 401 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2021 | 747 | 0.040 |
Why?
|
Morphogenesis | 1 | 2021 | 752 | 0.040 |
Why?
|
Sports | 1 | 2003 | 688 | 0.040 |
Why?
|
Integrins | 1 | 2021 | 846 | 0.040 |
Why?
|
Failure to Thrive | 1 | 2017 | 137 | 0.040 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 64 | 0.040 |
Why?
|
Parenting | 1 | 2022 | 679 | 0.040 |
Why?
|
Isomerism | 1 | 1996 | 201 | 0.040 |
Why?
|
Mobility Limitation | 1 | 2020 | 409 | 0.040 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2000 | 357 | 0.040 |
Why?
|
Placenta | 1 | 2005 | 1699 | 0.040 |
Why?
|
DNA Probes | 4 | 1990 | 560 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2021 | 720 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2018 | 15520 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1247 | 0.030 |
Why?
|
Electron Transport | 1 | 2017 | 211 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 562 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2019 | 6994 | 0.030 |
Why?
|
Globins | 1 | 2017 | 416 | 0.030 |
Why?
|
Mitochondria | 2 | 2021 | 3514 | 0.030 |
Why?
|
Alternative Splicing | 2 | 2014 | 1117 | 0.030 |
Why?
|
Glycoproteins | 2 | 2005 | 2266 | 0.030 |
Why?
|
Glucuronidase | 1 | 2017 | 207 | 0.030 |
Why?
|
Anticipation, Psychological | 1 | 2016 | 87 | 0.030 |
Why?
|
Neural Conduction | 1 | 2017 | 440 | 0.030 |
Why?
|
Erythroid Cells | 1 | 2017 | 239 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3524 | 0.030 |
Why?
|
Aged | 13 | 2019 | 163284 | 0.030 |
Why?
|
Reflex | 1 | 2017 | 365 | 0.030 |
Why?
|
Brain | 8 | 2005 | 26386 | 0.030 |
Why?
|
Prospective Studies | 5 | 2022 | 53291 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2021 | 767 | 0.030 |
Why?
|
Gait Disorders, Neurologic | 1 | 2017 | 231 | 0.030 |
Why?
|
Amblyopia | 1 | 1997 | 143 | 0.030 |
Why?
|
Pilot Projects | 2 | 2021 | 8319 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2007 | 19905 | 0.030 |
Why?
|
Molecular Biology | 1 | 1998 | 596 | 0.030 |
Why?
|
CpG Islands | 1 | 2019 | 1171 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1988 | 0.030 |
Why?
|
Action Potentials | 2 | 2017 | 1806 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2019 | 674 | 0.030 |
Why?
|
Cyclin E | 1 | 2015 | 172 | 0.030 |
Why?
|
Research Personnel | 1 | 2019 | 573 | 0.030 |
Why?
|
Reference Values | 4 | 2006 | 4982 | 0.030 |
Why?
|
Confidentiality | 1 | 2019 | 612 | 0.030 |
Why?
|
Phosphoglycerate Kinase | 2 | 1995 | 68 | 0.030 |
Why?
|
Escherichia coli | 1 | 2006 | 4217 | 0.030 |
Why?
|
Patient Selection | 2 | 2018 | 4216 | 0.030 |
Why?
|
Ion Channel Gating | 2 | 2009 | 437 | 0.030 |
Why?
|
New Hampshire | 1 | 1994 | 172 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 711 | 0.030 |
Why?
|
Apolipoprotein A-II | 1 | 1994 | 39 | 0.030 |
Why?
|
Birefringence | 1 | 2013 | 56 | 0.030 |
Why?
|
Neurons | 3 | 2009 | 9340 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2017 | 913 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 1999 | 1997 | 0.030 |
Why?
|
Genes, Retinoblastoma | 1 | 1994 | 136 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2014 | 86 | 0.030 |
Why?
|
Electroencephalography | 2 | 2019 | 6150 | 0.030 |
Why?
|
Respiration Disorders | 1 | 2017 | 371 | 0.030 |
Why?
|
Scoliosis | 1 | 2020 | 725 | 0.030 |
Why?
|
Freezing | 1 | 2014 | 303 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2017 | 931 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
Glioma | 1 | 1988 | 3401 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2018 | 10484 | 0.030 |
Why?
|
NAD | 1 | 2017 | 590 | 0.030 |
Why?
|
Electrocardiography | 4 | 2002 | 6442 | 0.030 |
Why?
|
Gene Amplification | 1 | 1998 | 1063 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2021 | 1827 | 0.030 |
Why?
|
Ontario | 1 | 1994 | 383 | 0.030 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 320 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2015 | 463 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 967 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2018 | 1549 | 0.030 |
Why?
|
Open Reading Frames | 2 | 2012 | 811 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 1971 | 0.030 |
Why?
|
Access to Information | 1 | 2016 | 320 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2017 | 706 | 0.030 |
Why?
|
PAX7 Transcription Factor | 1 | 2012 | 53 | 0.030 |
Why?
|
Pyridostigmine Bromide | 1 | 2012 | 31 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2023 | 63115 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2017 | 598 | 0.030 |
Why?
|
Organ Specificity | 2 | 2004 | 2008 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2021 | 1901 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6387 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 465 | 0.030 |
Why?
|
Family Health | 2 | 2012 | 1281 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 9957 | 0.030 |
Why?
|
Informed Consent | 1 | 2018 | 995 | 0.030 |
Why?
|
Body Size | 1 | 2015 | 461 | 0.030 |
Why?
|
Spectrin | 1 | 1992 | 177 | 0.030 |
Why?
|
Motor Neurons | 1 | 2017 | 844 | 0.030 |
Why?
|
Electromyography | 1 | 2017 | 1379 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 817 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2003 | 2897 | 0.030 |
Why?
|
Antibodies | 2 | 1997 | 2460 | 0.030 |
Why?
|
Neuregulin-1 | 1 | 2012 | 142 | 0.020 |
Why?
|
Skin | 2 | 2019 | 4371 | 0.020 |
Why?
|
Receptors, Cholinergic | 1 | 2012 | 238 | 0.020 |
Why?
|
Retina | 1 | 2002 | 2616 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2019 | 3617 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1677 | 0.020 |
Why?
|
Peripheral Nerves | 1 | 2015 | 466 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2005 | 8432 | 0.020 |
Why?
|
Information Dissemination | 1 | 2019 | 1099 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1085 | 0.020 |
Why?
|
Plasmids | 2 | 1986 | 2308 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2014 | 684 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1997 | 2649 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2015 | 749 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1607 | 0.020 |
Why?
|
Mothers | 1 | 2021 | 2165 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1041 | 0.020 |
Why?
|
Methylprednisolone | 1 | 1992 | 387 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
Leukocytes | 1 | 2018 | 2045 | 0.020 |
Why?
|
Rotarod Performance Test | 1 | 2010 | 64 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 781 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1356 | 0.020 |
Why?
|
Blood Proteins | 1 | 1995 | 1124 | 0.020 |
Why?
|
Intermediate Filaments | 1 | 2010 | 175 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2255 | 0.020 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2012 | 431 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2014 | 57776 | 0.020 |
Why?
|
Rabbits | 1 | 1996 | 4894 | 0.020 |
Why?
|
Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.020 |
Why?
|
Ornithine Carbamoyltransferase | 1 | 1989 | 25 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9849 | 0.020 |
Why?
|
Mitosis | 1 | 2015 | 1208 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 25041 | 0.020 |
Why?
|
Cadherins | 1 | 2014 | 907 | 0.020 |
Why?
|
Fluorescence | 1 | 1992 | 751 | 0.020 |
Why?
|
Cricetinae | 2 | 1995 | 2475 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2021 | 1900 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1999 | 2866 | 0.020 |
Why?
|
Factor IX | 1 | 1989 | 77 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3771 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 1995 | 1058 | 0.020 |
Why?
|
Regression Analysis | 2 | 2016 | 6459 | 0.020 |
Why?
|
Caregivers | 1 | 2021 | 2095 | 0.020 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 1988 | 14 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 1060 | 0.020 |
Why?
|
Extremities | 1 | 2014 | 866 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1297 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 1999 | 4464 | 0.020 |
Why?
|
Calpain | 1 | 2009 | 150 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3888 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2494 | 0.020 |
Why?
|
Emotions | 2 | 2016 | 2658 | 0.020 |
Why?
|
Nuclear Envelope | 1 | 2009 | 172 | 0.020 |
Why?
|
Guanine | 1 | 1989 | 274 | 0.020 |
Why?
|
Cytosine | 1 | 1989 | 216 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2223 | 0.020 |
Why?
|
Homeostasis | 2 | 2009 | 3339 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1723 | 0.020 |
Why?
|
Sarcolemma | 2 | 1999 | 66 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1860 | 0.020 |
Why?
|
Risk Factors | 4 | 2021 | 72295 | 0.020 |
Why?
|
Neural Crest | 1 | 1990 | 275 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1801 | 0.020 |
Why?
|
Health Status | 1 | 2021 | 4033 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2008 | 323 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 2682 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 937 | 0.020 |
Why?
|
Jews | 1 | 2009 | 385 | 0.020 |
Why?
|
Automation | 1 | 2009 | 584 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2012 | 1085 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1775 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 2859 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1692 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1989 | 625 | 0.020 |
Why?
|
Viral Proteins | 1 | 1994 | 1900 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 552 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2009 | 340 | 0.020 |
Why?
|
Receptor, Serotonin, 5-HT1A | 1 | 2006 | 53 | 0.020 |
Why?
|
Azacitidine | 1 | 1988 | 347 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1678 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2926 | 0.020 |
Why?
|
Mutagenesis | 1 | 2010 | 1264 | 0.020 |
Why?
|
Meningioma | 1 | 1995 | 1209 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3527 | 0.020 |
Why?
|
Gene Targeting | 1 | 2010 | 880 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2017 | 2752 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2924 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2011 | 810 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12262 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1995 | 2441 | 0.020 |
Why?
|
Meningeal Neoplasms | 1 | 1995 | 1241 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6539 | 0.020 |
Why?
|
Oligodendroglia | 1 | 1990 | 517 | 0.020 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 55 | 0.020 |
Why?
|
Cell Fractionation | 1 | 2006 | 252 | 0.020 |
Why?
|
Cholesterol | 1 | 2015 | 2919 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1986 | 261 | 0.020 |
Why?
|
Receptors, Mitogen | 1 | 2005 | 62 | 0.020 |
Why?
|
Mice, Inbred mdx | 1 | 2005 | 89 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1178 | 0.020 |
Why?
|
Calcium Channels | 1 | 2009 | 622 | 0.020 |
Why?
|
Electrophoresis | 1 | 2005 | 240 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2017 | 1736 | 0.020 |
Why?
|
Spectrophotometry | 1 | 2005 | 313 | 0.020 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1986 | 207 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2009 | 976 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1994 | 1345 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2008 | 690 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1992 | 1813 | 0.020 |
Why?
|
Fetal Diseases | 1 | 1990 | 903 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2008 | 436 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3064 | 0.020 |
Why?
|
Epithelium | 1 | 1990 | 1679 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 1986 | 362 | 0.020 |
Why?
|
Models, Genetic | 2 | 2012 | 3493 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1862 | 0.020 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 322 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3873 | 0.020 |
Why?
|
Karyotyping | 1 | 1986 | 1243 | 0.020 |
Why?
|
Centrosome | 1 | 2005 | 201 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2007 | 940 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2009 | 1686 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7730 | 0.010 |
Why?
|
RNA, Complementary | 1 | 2003 | 45 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3309 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4851 | 0.010 |
Why?
|
RNA Probes | 1 | 2003 | 113 | 0.010 |
Why?
|
Statistical Distributions | 1 | 2003 | 64 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1990 | 1236 | 0.010 |
Why?
|
Adenoma | 1 | 1994 | 2174 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 2007 | 970 | 0.010 |
Why?
|
Xenopus | 1 | 2005 | 712 | 0.010 |
Why?
|
DNA, Viral | 1 | 1990 | 2227 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9312 | 0.010 |
Why?
|
Epitopes | 1 | 1989 | 2571 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 2003 | 319 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3465 | 0.010 |
Why?
|
Ocular Hypotension | 1 | 2002 | 22 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 35424 | 0.010 |
Why?
|
Astrocytes | 1 | 1990 | 1273 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5882 | 0.010 |
Why?
|
Electrophysiology | 1 | 2005 | 1308 | 0.010 |
Why?
|
Gene Components | 1 | 2001 | 29 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3922 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4839 | 0.010 |
Why?
|
Muridae | 1 | 2001 | 61 | 0.010 |
Why?
|
Prognosis | 2 | 2001 | 29060 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2204 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3706 | 0.010 |
Why?
|
Glycine | 1 | 2005 | 671 | 0.010 |
Why?
|
Depression | 1 | 2021 | 7766 | 0.010 |
Why?
|
Histocytochemistry | 1 | 2002 | 719 | 0.010 |
Why?
|
Cadaver | 1 | 2005 | 1337 | 0.010 |
Why?
|
Cognition Disorders | 1 | 1996 | 4043 | 0.010 |
Why?
|
Molecular Probes | 1 | 2003 | 316 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1837 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5984 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6366 | 0.010 |
Why?
|
Endocytosis | 1 | 2005 | 985 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2005 | 1880 | 0.010 |
Why?
|
Physical Endurance | 1 | 2003 | 370 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15078 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 816 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5974 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1988 | 6314 | 0.010 |
Why?
|
Oocytes | 1 | 2005 | 1188 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2002 | 964 | 0.010 |
Why?
|
Restriction Mapping | 2 | 1991 | 878 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10400 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 1991 | 5868 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20950 | 0.010 |
Why?
|
Neuropilin-1 | 1 | 1999 | 90 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5445 | 0.010 |
Why?
|
Optic Nerve | 1 | 2002 | 554 | 0.010 |
Why?
|
Running | 1 | 2003 | 480 | 0.010 |
Why?
|
Utrophin | 1 | 1997 | 15 | 0.010 |
Why?
|
Up-Regulation | 1 | 2007 | 4222 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 13882 | 0.010 |
Why?
|
Nuclear Family | 1 | 1999 | 318 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1660 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 3130 | 0.010 |
Why?
|
Acute Disease | 1 | 2008 | 7147 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3493 | 0.010 |
Why?
|
Kv1.4 Potassium Channel | 1 | 1997 | 3 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1998 | 829 | 0.010 |
Why?
|
Neuronal Apoptosis-Inhibitory Protein | 1 | 1996 | 12 | 0.010 |
Why?
|
RNA Interference | 1 | 2006 | 2891 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4583 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1996 | 118 | 0.010 |
Why?
|
Dimerization | 1 | 1998 | 895 | 0.010 |
Why?
|
Gene Library | 1 | 1999 | 1074 | 0.010 |
Why?
|
Proteomics | 1 | 2009 | 3638 | 0.010 |
Why?
|
Ion Channels | 1 | 2001 | 1056 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 1995 | 69 | 0.010 |
Why?
|
Neutrophils | 1 | 2008 | 3721 | 0.010 |
Why?
|
Crohn Disease | 1 | 2008 | 2304 | 0.010 |
Why?
|
Bone Marrow | 1 | 2006 | 2948 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40077 | 0.010 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1996 | 403 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2001 | 1701 | 0.010 |
Why?
|
Macrophages | 1 | 1990 | 5660 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1240 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1996 | 8862 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1995 | 351 | 0.010 |
Why?
|
Proteolipids | 1 | 1994 | 117 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1991 | 9274 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 1996 | 802 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 4458 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 491 | 0.010 |
Why?
|
Genome | 1 | 2001 | 1807 | 0.010 |
Why?
|
Methylation | 1 | 1995 | 1106 | 0.010 |
Why?
|
Glaucoma | 1 | 2002 | 1159 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2001 | 1541 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2001 | 1939 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1998 | 1169 | 0.010 |
Why?
|
Linear Models | 1 | 2002 | 5952 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1995 | 982 | 0.010 |
Why?
|
Antisense Elements (Genetics) | 1 | 1991 | 37 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20823 | 0.010 |
Why?
|
Genomic Library | 1 | 1991 | 193 | 0.010 |
Why?
|
Rats | 2 | 1998 | 24252 | 0.010 |
Why?
|
Lymphocytes | 1 | 1998 | 2617 | 0.010 |
Why?
|
Deoxyribonuclease HindIII | 1 | 1989 | 15 | 0.010 |
Why?
|
DNA Restriction Enzymes | 1 | 1990 | 570 | 0.010 |
Why?
|
Reading Frames | 1 | 1989 | 18 | 0.010 |
Why?
|
Sarcoma | 1 | 2001 | 1897 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6621 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1992 | 514 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1991 | 1095 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1994 | 1758 | 0.010 |
Why?
|
Synapses | 1 | 1998 | 1728 | 0.010 |
Why?
|
Cross Reactions | 1 | 1989 | 841 | 0.000 |
Why?
|
Kidney Failure, Chronic | 1 | 2000 | 2535 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1998 | 8300 | 0.000 |
Why?
|
Survival Rate | 1 | 2001 | 12788 | 0.000 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1997 | 2916 | 0.000 |
Why?
|
Sleep | 1 | 2001 | 4623 | 0.000 |
Why?
|
Pregnancy | 1 | 2006 | 29144 | 0.000 |
Why?
|
Exercise | 1 | 2001 | 5615 | 0.000 |
Why?
|
Hippocampus | 1 | 1997 | 3675 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2005 | 13104 | 0.000 |
Why?
|
Kidney | 1 | 1995 | 7184 | 0.000 |
Why?
|